Peripherally acting M-opioid receptor antagonists can improve quality of life but differ variably by impact from concomitant medications.
Amelia L. Persico, Pharm D, MBA
Advertisement
Articles by Amelia L. Persico, Pharm D, MBA
Advertisement
Latest Updated Articles
Toxicity Is a Risk of PAMORA InteractionsJuly 1st 2020
Advertisement
Advertisement
Trending on Pharmacy Times
1
Medicare Is Finally Covering GLP-1s for Weight Loss: What the Bridge Program Means for Your Practice
2
Olezarsen Receives FDA Approval to Reduce Triglycerides, Risk of Acute Pancreatitis in Severe Hypertriglyceridemia
3
ADA 2026: Diabetes Technology Innovations Expand Beyond Traditional CGM Use
4
FAQs Amid the Ongoing US Measles Outbreaks
5